Furthermore, it suggests that miR147-mediated reduction in Ndufa4 expression may offer a therapeutic opportunity in colorectal (and other) cancer treatment by overexpression of miR147 (utilizing miR147 mimetics), which would lead to a diminished capacity to utilize glycolysis by the tumor cells and to tumor cell death. Here, COXFA4 is linked to cancer.